Literature DB >> 22825055

[Therapy of septic paraplegia].

M Keil1, L Szczerba, G Kraus, R Abel.   

Abstract

The frequency of infectious diseases of the spine and associated spinal cord injury are constantly increasing. Affected are multimorbid and elderly patients, mostly after prolonged medical treatment. An acute spinal cord injury due to infection is an emergency. A rapid decision for treatment strategy and if at all possible subtle debridement of the infected tissue with decompression of the spinal cord is paramount. Additionally spinal cord injury necessitates specialized treatment and care of the infection. Spinal cord injured patients in general and these patients in particular are prone to complications and need especially trained nursing personnel. It is therefore recommended that patients with vertebral osteomyelitis associated with spinal cord injury should be transferred to dedicated centres of treatment as soon as possible.Just as in cases of spondylodiscitis without spinal cord injury inconsistent surgical or insufficient antibiotic treatment worsens the prognosis significantly. If it is possible to remit the infection, the prognosis for recovery of motor and sensory function is better than in cases with traumatic spinal cord injury. In many cases at least partial recovery can be observed.

Entities:  

Mesh:

Year:  2012        PMID: 22825055     DOI: 10.1007/s00132-012-1918-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  17 in total

1.  Pyogenic non-tuberculous spinal infection: an analysis of thirty cases.

Authors:  J M Digby; J B Kersley
Journal:  J Bone Joint Surg Br       Date:  1979-02

2.  The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I.

Authors:  H L Frankel; D O Hancock; G Hyslop; J Melzak; L S Michaelis; G H Ungar; J D Vernon; J J Walsh
Journal:  Paraplegia       Date:  1969-11

3.  [Paraplegia in cases of septic diseases of the spine].

Authors:  M Keil; M Akbar; R Abel
Journal:  Orthopade       Date:  2005-02       Impact factor: 1.087

4.  A case ascertainment study of septic discitis: clinical, microbiological and radiological features.

Authors:  N Hopkinson; J Stevenson; S Benjamin
Journal:  QJM       Date:  2001-09

5.  Single-stage autogenous bone grafting and internal fixation in the surgical management of pyogenic discitis and vertebral osteomyelitis.

Authors:  G J Przybylski; A D Sharan
Journal:  J Neurosurg       Date:  2001-01       Impact factor: 5.115

6.  Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases.

Authors:  J D Colmenero; M E Jiménez-Mejías; F J Sánchez-Lora; J M Reguera; J Palomino-Nicás; F Martos; J García de las Heras; J Pachón
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

7.  A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features.

Authors:  C D'Agostino; L Scorzolini; A P Massetti; M Carnevalini; G d'Ettorre; M Venditti; V Vullo; G B Orsi
Journal:  Infection       Date:  2010-02-27       Impact factor: 3.553

8.  Sagittal alignment after anterior debridement and fusion with or without additional posterior instrumentation in the treatment of pyogenic and tuberculous spondylodiscitis.

Authors:  Constantin Klöckner; Ray Valencia
Journal:  Spine (Phila Pa 1976)       Date:  2003-05-15       Impact factor: 3.468

9.  Pyogenic vertebral osteomyelitis with paralysis. Prognosis and treatment.

Authors:  M Liebergall; G Chaimsky; J Lowe; G C Robin; Y Floman
Journal:  Clin Orthop Relat Res       Date:  1991-08       Impact factor: 4.176

10.  [Urogenic spondylodiscitis].

Authors:  E K Renker; K Möhring; R Abel; C Carstens; B Wiedenhöfer; B Lehner; T Bruckner; M Akbar
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

View more
  1 in total

1.  Spondylodiscitis severity code: scoring system for the classification and treatment of non-specific spondylodiscitis.

Authors:  L Homagk; N Homagk; J R Klauss; K Roehl; G O Hofmann; D Marmelstein
Journal:  Eur Spine J       Date:  2015-04-21       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.